FDA approves new medication for chronic weight management, FDA (2023) Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review, NIH (2022) Mounjaro- tirzepatide injection, Eli Lilly (2023) Mounjarotm (tirzepatide) injection, FDA (2022) Lillys tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks, Eli Lilly (2023) How to use Mounjaro, Eli Lilly (2023) Mounjaro dietary instructions, CNMRI (2023) Weekly exercise targets, American Diabetes Association (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Lupus is an autoimmune disease, meaning the immune system attacks the bodys own tissues, causing inflammation
[1] [2] This is particularly valuable given the strong association between obesity and type 2 diabetes complications
8 A comparative randomized trial in patients with type 2 diabetes also found modestly but significantly greater weight loss with oral semaglutide than with SC liraglutide
From dietary changes to medical interventions, people seeking to lose weight often wonder which approach will yield the best results
Non-oral contraceptives: Neither medication affects non-oral contraceptives, including: Contraceptive patch Vaginal ring Hormonal IUD (coil) Contraceptive implant Contraceptive injection If youre currently using the pill while on Mounjaro and want to continue using oral contraception after switching, Wegovy offers the advantage of no interaction concerns
